Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

SAN JOSE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced ...
StreetInsider.com

FDA accepts Rani Therapeutics' RaniPill platform into emerging tech program

Rani Therapeutics Holdings (Nasdaq: RANI) announced that its RaniPill Capsule platform technology has been accepted into the U.S. Food and Drug Administration's Emerging Technology Program ...
RTTNews

Rani Therapeutics' RaniPill Accepted Into FDA Emerging Technology Program

Rani Therapeutics Holdings, Inc. ( RANI) on Monday announced that its RaniPill Capsule platform technology has been accepted into the U.S. FDA's Emerging Technology Program (ETP).
Nasdaq

Avant Technologies and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback

LAS VEGAS, July 29, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions, and its Joint Venture partner ...
RAPS

FDA Finalizes Guidance on Emerging Manufacturing Tech Program

The US Food and Drug Administration (FDA) on Thursday finalized its guidance detailing how drugmakers can participate in the agency's program to advance the use of emerging manufacturing technologies, ...